Universal Health Services... (UHS)
NYSE: UHS
· Real-Time Price · USD
170.97
-2.69 (-1.55%)
At close: Jun 13, 2025, 3:59 PM
171.07
0.06%
After-hours: Jun 13, 2025, 05:29 PM EDT
Universal Health Services Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute Care Hospital Services Revenue | 8.92B | 44.69B | 40B | 36.52B | 30.56B | 28.43B | 24.81B | 21.89B | 19.04B | 16.85B | 14.94B | 13.47B | 18M | 12.03B |
| Acute Care Hospital Services Revenue Growth | -80.03% | +11.70% | +9.54% | +19.50% | +7.50% | +14.57% | +13.37% | +14.94% | +13.03% | +12.75% | +10.94% | +74729.27% | -99.85% | n/a |
| Behavioral Health Services Revenue | 6.9B | 10.65B | 10.12B | 9.93B | 9.72B | 10.1B | 9.74B | 8.95B | 8.02B | 7.46B | 6.69B | 6.29B | n/a | 5.53B |
| Behavioral Health Services Revenue Growth | -35.25% | +5.26% | +1.91% | +2.14% | -3.78% | +3.75% | +8.78% | +11.63% | +7.53% | +11.46% | +6.29% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.99B | 1.95B | 1.95B | 1.89B | 1.88B | 1.83B | 1.82B | 1.81B | 1.79B | 1.74B | 1.71B | 1.72B | 1.72B | 1.65B | 1.58B | 1.52B | 1.53B | 1.5B | 1.43B | 1.34B | 1.46B | 1.46B | 1.44B | 1.41B | 1.39B | 1.36B | 1.34B | 1.33B | 1.33B | 1.28B | 1.28B | 1.26B | 1.26B | 1.18B | 1.17B | 1.16B | 1.17B | 1.1B | 1.08B | 1.07B | 1.05B |
| Selling, General, and Administrative Revenue Growth | +2.17% | -0.16% | +2.97% | +0.77% | +2.39% | +0.76% | +0.81% | +0.97% | +3.03% | +1.46% | -0.73% | -0.06% | +4.39% | +4.23% | +4.47% | -0.79% | +2.13% | +4.34% | +7.38% | -8.54% | +0.13% | +1.62% | +1.83% | +1.32% | +2.49% | +1.12% | +0.73% | +0.47% | +3.61% | +0.22% | +1.22% | -0.07% | +6.96% | +0.64% | +1.54% | -1.44% | +6.24% | +2.03% | +1.36% | +1.20% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |